Abstract
Hypertrophic cardiomyopathy (HCM) is a highly arrhythmogenic primary heart muscle disease. Clinical manifestations are variable ranging from a benign asymptomatic course to severe heart failure and cardiac arrest. Ventricular arrhythmias, palpitations and syncope are frequent signs and symptoms. Sudden, unexpected cardiac arrest is a pending catastrophe in the natural history of HCM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology and therapy (1). N Engl J Med 316:780–789 and 844-852
Teare RD (1958) Asymmetrical septal hypertrophy of the heart in young adults. Br Heart J 20:1–8
Braunwald E, Morrow AG, Cornell WP, Aygen MM, Hilbish TF (1960) Idiopathic hypertrophic subaortic stenosis. Am J Med 29:924–945
Wigle ED, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92:1680–1692
Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophie cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26:1699–1708
Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG (1985) Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cadiovasc Dis 28:1–83
Brugada P, Bar FWHM, De Zwann C, Roy D, Green M, Wellens HJJ (1982) “Sawfish ” systolic narrowing of the left anterior descending coronary artery: an angiographie sign of hypertrophie cardiomyopathy. Circulation 66:800–803
Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophie cardiomyopathy. Circulation 59:689–706
Maron BJ, Anan TJ, Roberts WC (1981) Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 63:882–894
Ferrans VJ, Rodriguez ER (1983) Specificity of light and electron microscopic features of hypertrophie obstructive and nonobstructive cardiomyopathy. Qualitative, quantitative and etiologic aspects. Eur Heart J 4 [Suppl F]:9–22
StJohn Sutton MG, Lie JT, Anderson KR, O’Brien PC, Frye RL (1980) Histologie specificity of hypertrophie obstructive cardiomyopathy: myocardial fiber disarray and myocardial fibrosis. Br Heart J 44:433–443
Factor SM, Butany J, Sole MJ, Wigle ED, Williams WC, Pojkind M (1991) Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 17:1343–1351
Davies MJ, McKenna WJ (1995) Hypertrophic cardiomyopathy-pathology and pathogenesis. Histopathology 26:493–500
Maron BJ, Epstein SE, Roberts WC (1979) Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 43:1086–1102
Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel ”) coronary artery disease in hypertrophie cardiomyopathy. J Am Coll Cardiol 8:545–557
Slade AKB, Saumarez RC, McKenna WJ (1993) The arrhythmogenic substrate-diagnostic and therapeutic implications: hypertrophie cardiomyopathy. Eur Heart J 14 [Suppl E]:84–90
Morrow AG, Brockenbrough EC (1961) Surgical treatment of idiopathic hypertrophie subaortic stenosis: technique and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 154:181–189
Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775–785
Wigle ED, Wilansky S (1987) Diastolic dysfunction in hypertrophie cardiomyopathy. Heart Failure 3:82–93
Maron BJ, Spirito P, Greene KJ, Wesley YE, Bonow RO, Arce J (1987) Non invasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophie cardiomyopathy. J Am Coll Cardiol 10:733–742
Inoue T, Morooka S, Hayashi T, Takayanagi K, Sakai Y, Fujito T, Fujinuma S, Takabatake Y (1991) Global and regional abnormalities of left ventricular diastolic filling in hypertrophie cardiomyopathy. Clin Cardiol 14:573–577
Shirani J, Maron BJ, Cannon III RO, Shahin S, Roberts WC (1993) Clinico-pathologic features of hypertrophie cardiomyopathy managed by cardiac transplantation. Am J Cardiol 72:434–440
Boffa GM, Thiene G, Nava A, Dalla Volta S (1991) Cardiomyopathy: a necessary revision of the WHO classification. Int J Cardiol 30:1–7
Boffa GM, Chioin R, Pellegrino PA, Scognamiglio R, Fasoli G, Razzolini R, Milanesi O, Thiene G (1983) Cardiomiopatia restrittiva primaria. Rev Lat Cardiol 4:263–275
Angelini A, Calzolari V, Boffa GM, Calabrese F, Valente M, Thiene G (1995) Primary restrictive cardiomyoapthy. Eur Heart J 16 [Suppl]:395 (abstr)
Maron BJ, Lang L, Moller JH, Edwards JE (1980) Cardiomyopathies characterized by evidence of resistence to left ventricular inflow. Cathet Cardiovasc Diag 6:29–39
Arbustini E, Buonanno C, Trevi P, Pennelli N, Ferrans VJ, Thiene G (1983) Cardiac ultrastructure in primary restrictive cardiomyopathy. Chest 84:236–238
Edwards WD (1987) Cardiomyopathies. Hum Pathol 18:625–635
Katritsis D, Wilmshurst PT, Wendon JA, Davies MJ, Webb-People MM (1991) Primary restrictive cardiomyopathy:clinical and pathologic characteristics. J Am Coll Cardiol 18:1230–1235
Aroney C, Bett N, Redford D (1988) Familial restrictive cardiomyopathy. Aust Nz J Med 18:877–878
McKenna WJ, Stewart JT, Nihoyannopoulos P, McGinfy F, Davies MJ (1990) Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 63:287–290
McKenna WJ, Camm AJ (1989) Sudden death in hypertrophie cardiomyopathy: assessment of patients at high risk. Circulation 80:1489–1492
Maron BJ, Fananapazir L (1992) Sudden death in hypertrophie cardiomyopathy. Circulation 85 [Suppl I]:57–63
Maron BJ, Roberts WJ, Epstein SE (1982) Sudden death in hypertrophie cardiomyopathy: a profile of 78 patients. Circulation 67:1388–1394
McKenna WJ, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J (1981) Prognosis in hypertrophie cardiomyopathy: role of age and clinical, electrocardiographic and hemodinamic features. Am J Cardiol 47:532–538
Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C (1989) Clinical course and prognosis of hypertrophie cardiomyopathy in an outpatient population. N Engl J Med 320:749–755
Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26:1529–1536
McKenna WJ, Deanfield JE (1984) Hypertrophic cardiomyopathy. An important cause of sudden death. Arch Dis Chil 59:971–975
McKenna WJ, Franklin RCG, Nihoyannopoulos P, Robinson KR, Deanfield JE (1988) Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 11:147–153
Spirito P, Maron BJ, Bonow RO, Epstein SE (1987) Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 60:123–129
Topaz O, Edwards JE (1985) Pathologic features of sudden death in children, adolescents and young adults. Chest 87:476–482
Burke AP, Farb A, Virmani R, Goodin J, Smialek JE (1991) Sports-related and non sports-related sudden cardiac death in young adults. Am Heart J 121:568–575
Basso C, Corrado D, Nava A, Dalla Volta S (1996) Hypertrophic cardiomyopathy: pathologic evidence of myocardial ischemie injury in young sudden death victims. Circulation 94 [Suppl]:I–427 (abstr)
Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE (1985) Myocardial ischemia in patients with hypertrophie cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 71:234–243
Dilsizian V, Bonow RO, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophie cardiomyopathy. J Am Coll Cardiol 22:796–804
Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE (1980) Sudden death in young athletes. Circulation 62:218–229
Corrado D, Basso C, Thiene G (1996) Pathologic findings in victims of sport-related sudden cardiac death. Sports Exercise and Injury 2:78–86
Corrado D, Thiene G, Nava A, Rossi L, Pennelli N (1990) Sudden death in young competitive athletes: clinico-pathologic correlations in 22 cases. Am J Med 89:588–596
Thiene G, Nava A, Corrado D, Rossi L, Pennelli N (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129–133
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Italia
About this paper
Cite this paper
Basso, C., Corrado, D., Angelini, A., Thiene, G. (1998). Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist’s View. In: Camerini, F., Gavazzi, A., De Maria, R. (eds) Advances in Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2155-6_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-2155-6_8
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2181-5
Online ISBN: 978-88-470-2155-6
eBook Packages: Springer Book Archive